Table 1.
The characteristics of the excluded and included patients.
| Excluded (n = 233) | Included (n = 416) | p-value | |
|---|---|---|---|
| Age (year), mean (SD) | 58.9 ± 12.7 | 58.8 ± 13.2 | 0.90 |
| Sex (male), n (%) | 146 (62.7) | 268 (64. 9) | 0.57 |
| Tobacco use, n (%) | 0.74 | ||
| Never | 149 (64.0) | 255 (61.3) | |
| Quit | 18 (7.7) | 38 (9.1) | |
| Current | 66 (28.3) | 123 (29.6) | |
| Body mass index, (kg/m2), mean (SD) | 24.9 ± 4.7 | 24.5 ± 3.8 | 0.36 |
| Medical history, n (%) | |||
| Diabetes mellitus | 20 (8.6) | 38 (9.1) | 0.81 |
| Hypertension | 146 (62.7) | 284 (68.3) | 0.15 |
| Dyslipidemia | 19 (8.2) | 18 (4.3) | 0.04 |
| Coronary heart disease | 18 (7.7) | 33 (7.9) | 0.93 |
| Atrial fibrillation | 3 (1.3) | 6 (1.4) | 1.00 |
| Heart failure | 0 (0.0) | 1 (0.3) | 1.00 |
| Family history of stroke | 18 (8.8) | 41 (10.6) | 0.48 |
| On admission status | |||
| NIHSS score, mean (SD) | 9.7 ± 8.2 | 8.7 ± 7.6 | 0.09 |
| median (IQR) | 9.0 (3.0–13.0) | 7.0 (2.0–13.0) | |
| GCS score, mean (SD) | 13.0 ± 3.0 | 13.3 ± 2.6 | 0.35 |
| median (IQR) | 15.0 (12.0–15.0) | 15.0 (12.0–15.0) | |
| Pre-morbid mRS | 6 (2.6) | 5 (1.2) | 0.33 |
| score> = 2, n (%) | |||
| SBP (mmHg), mean (SD) | 155.2 ± 24.1 | 155.1 ± 23.6 | 0.80 |
| DBP (mmHg), mean (SD) | 91.5 ± 14.2 | 90.7 ± 14.1 | 0.43 |
| Hematoma location, n (%) | 0.95 | ||
| Lobes | 26 (11.2) | 52 (12.5) | |
| Basal ganglia region | 168 (72.1) | 300 (72.1) | |
| Brain stem | 16 (6.9) | 23 (5.5) | |
| Cerebellum | 13 (5.6) | 22 (5.3) | |
| Extension to surrounding | 10 (4.3) | 19 (4.6) | |
| spaces | |||
| Laboratory values on admission | |||
| Fasting glucose, | 6.3 ± 2.4 | 6.2 ± 2.1 | 0.84 |
| (mmol/L), mean (SD) | |||
| HbA1c (%), Mean ±SD | 5.5 ± 1.1 | 5.8 ± 1.3 | 0.002 |
| Median (IQR) | 5.4 (4.8–5.9) | 5.7 (5.2–6.3) | |
| High density lipoprotein | 1.4 ± 0.7 | 1.3 ± 0.5 | 0.33 |
| (mmol/l), mean (SD) | |||
| Triglyceride (mmol/L), | 1.7 ± 1.4 | 1.8 ± 1.4 | 0.32 |
| mean (SD) | |||
| Medication in hospital, n (%) | |||
| Oral hypoglycemic agents | 20 (8.6) | 38 (9.1) | 0.81 |
| Insulin administration | 19 (8.2) | 31 (7.5) | 0.75 |
| Antihypertensive therapy | 151 (64.8) | 284 (68.3) | 0.37 |
| In-hospital complications n (%) | |||
| Pneumonia | 42 (18.0) | 61 (14.7) | 0.26 |
| UTI | 11 (4.7) | 31 (7.5) | 0.18 |
NIHSS, National Institutes of Health Stroke Scale; SD, standard deviation; IQR, interquartile; SAH, subarachnoid hemorrhage; Q, quartile; GCS, Glasgow coma scale; SBP, systolic blood pressure; DBP, diastolic blood pressure; mRS, modified Rankin scale; HbA1c, hemoglobin A1c; UTI, urine tract infection.